EFDID: 164732EFD: View Filing

Issuer: Salient Risk Parity Delta RHO Q V10 Fund, L.P. (0001672989) - D

Accession: 0001672989-16-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001672989
  • Entity Name:
    Salient Risk Parity Delta RHO Q V10 Fund, L.P.
  • Entity Type:
    Limited Partnership
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2016)
  • Address:
    4265 SAN FELIPE
    8TH FLOOR
    HOUSTON, TX 77027
  • Persons:
    Related Persons 8
    John A. Blaisdell
    Executive Officer
    Jeremy L. Radcliffe
    Executive Officer
    Lee G. Partridge
    Executive Officer
    Christopher Arnold
    Executive Officer
    Robert Naka
    Executive Officer
    Roberto Croce
    Executive Officer
    Paul Bachtold
    Executive Officer
    n/a Salient Liquid Alts GP, LLC
    Executive Officer 
    Salient Liquid Alts GP, LLC is the general partner of the Issuer.
EDGAR: Offering Information
  • Accession Date:
    05/12/2016
  • First Sale Date:
    05/02/2016
  • Offering Amount:
    Indefinite
  • Amount Sold:
    $50,000,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity, Pooled Investment Fund
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Blair Batson 5774604 Salient Capital, L.P. 147912 AZ
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Salient Risk Parity Delta RHO Q V10 Fund, L.P.John A. BlaisdellJohn A. BlaisdellChief Executive Officer2016-05-12
Related EDGAR Submissions
Type Edgar Date EFD: Accession
D/A Jun. 13, 2018 164732: 0001699288-18-000006 Salient Risk Parity Delta RHO Q V10 Fund, L.P.
Amount Sold: $70,030,000
D/A Jun. 13, 2017 164732: 0001672989-17-000001 Salient Risk Parity Delta RHO Q V10 Fund, L.P.
Amount Sold: $50,010,000
D May. 12, 2016 164732: 0001672989-16-000001 Salient Risk Parity Delta RHO Q V10 Fund, L.P.
Amount Sold: $50,000,000